New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said that Europe’s approval for the covishield vaccine produced locally is “only time problems” and expected in about a month.
The European Medicine Agency (EMA) has not yet cleared the inclusion of Covishield in the European Union (EU) Covid Vaccination.
Until approved, anyone who has been fully vaccinated with Covishield will not be able to travel to Europe during a pandemic.
Also read Jaishankar raised the green pass for the Covishield with Minister of Euishankar Euishankar said that he had increased the problem of European authorization for the Covishield vaccine to travel to the EU with Josep Borell Fontelles, a high representative for the EU in the policy.
The European Union ‘Passport’ Passport ‘program, was officially called’ Green Pass’, Hasspeaking to PTI, Poonawalla said there was no reason why EMA would not approve the covishield because this vaccine was originally developed by Astrazeneca and was less more identical to one produced in the UK.
“We are quite sure that in a month EMA will approve the covishield.
There is no reason not to do it, because it is based on AstraZeneca data and our products are identical to Astrazeneca more or less and have been approved by WHO, UK Mhra.
So it’s just a matter of time.
It’s not true -Tar will block anything, “he added.
He said that SII had submitted a request for the covishield inclusion through his partner astrazeneca.
“EMA is really true in asking us to register, which we have through AstraZeneca, our partners, a month ago, and the process must take time.
The approval process even with UK Mhra, who applied for time and we have applied.
To EMA, “Poonawalla said in India forum Global 2021.
On Tuesday, EU officials (EU) had notified the news agency Ani that EMA had not received a covishield approval request.
Pune-based companies previously urged the government to take problems with the European Union and other countries.
It is said that non-inclusion of covishield will affect students and business travelers.
At present, only four vaccines – Comirnaty of Pfizer / Biontech, Modera, Vaxzervia by Astrazeneca-Oxford and, Johnson & Johnson’s Janssen – have been approved by the European Medicine Agency (EMA).
EU Green Passa EU vaccine passport program will allow people to travel freely in a block from July 1, as long as they have one of these vaccines.
On Monday, the ministry of external affairs also raised the issue of lack of recognition of covishield by the European Medicine Agency (EMA).
Foreign Minister S Jaishankar, in Italy for the G20 Summit, said he took a problem with the top European Union officials and promised to follow up on this problem.
Last year, Astrazeneca partnered with SII to supply vaccines to the Indian government, as well as a large number of low and medium-sized income countries.
Covishield accounts for around 88% of 322 million doses so far being managed in India, the Cowin vaccination registration platform in the country shows.
Many were vaccinated with Indian Covaxin shots also faced trouble trouble, because it had not been approved by WHO.
(With input from agency)